Results 131 to 140 of about 19,293 (297)

Mesotelioma peritoneal. A propósito de un caso [PDF]

, 2019
El mesotelioma peritoneal maligno difuso (MPM) es una neoplasia de infrecuente aparición que surge de las células mesoteliales del peritoneo. Tiene una incidencia aproximada de 2500 casos al año a escala mundial.
Calderón Martínez, Gonzalo
core  

Laparoscopic Cytoreduction Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Surface Malignancies (PSM): Italian PSM Oncoteam Evidence and Literature Review [PDF]

, 2022
Antonio Sommariva, Mario Valle, Roberta Gelmini, Marco Tonello, Fabio Carboni, Giovanni De Manzoni, Lorena Sorrentino, Enrico Maria Pasqual, Stefano Bacchetti, C. Sassaroli, Andrea Di Giorgio, Massimo Framarini, Daniele Marrelli, Francesco Casella, Orietta Federici   +14 more
openalex   +1 more source

Hyperthermic intraperitoneal chemotherapy (HIPEC) for the management of primary advanced and recurrent ovarian cancer: a systematic review and meta-analysis of randomized trials

ESMO Open, 2022
P. Filis, D. Mauri, G. Markozannes, M. Tolia, N. Filis, K. Tsilidis   +5 more
semanticscholar   +1 more source

Complications of Cytoreductive Surgery and HIPEC in the Treatment of Peritoneal Metastases [PDF]

, 2016
Sanket Mehta, Maximiliano Gelli, Deepesh Agarwal, Diane Goèré   +3 more
openalex   +1 more source

An update of peritonectomy procedures used in cytoreductive surgery for peritoneal malignancy

International Journal of Hyperthermia, 2019
Background: Complete cytoreduction is acknowledged to be an effective way to achieve macroscopic tumor clearance for a variety of tumors confined to the peritoneal cavity.
Frédéric Mercier, Faheez Mohamed, Jean-Baptiste Cazauran, Vahan Kepenekian, Delphine Vaudoyer, Eddy Cotte, Olivier Glehen, Guillaume Passot   +7 more
doaj   +1 more source

Pulmonary toxicity after intraperitoneal mitomycin C: a case report of a rare complication of HIPEC [PDF]

, 2017
Melissa L. Abel, George Kokosis, Dan G. Blazer   +2 more
openalex   +1 more source

Hyperthermic intraperitoneal chemotherapy in patients with incomplete cytoreduction for appendiceal pseudomyxoma peritonei: a 10-year treatment experience in China

Orphanet Journal of Rare Diseases
Background To explore the application value of hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with incomplete cytoreduction for appendiceal pseudomyxoma peritonei (PMP). Methods We retrospectively analyzed the clinical data of 526 patients
Bing Wang, Ruiqing Ma, Guanjun Shi, Xiwen Fan, Benqiang Rao, Hongbin Xu   +5 more
doaj   +1 more source

Can Elderly Patients with Peritoneal Metastasis Induced by Appendiceal or Colorectal Tumours Benefit from Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)?

Clinical Interventions in Aging, 2021
Sicheng Zhou,1,* Qiang Feng,1,* Jing Zhang,2 Haitao Zhou,1 Zheng Jiang,1 Jianwei Liang,1 Wei Pei,1 Qian Liu,1 Zhixiang Zhou,1 Xishan Wang1 1Department of Colorectal Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer ...
Zhou S, Feng Q, Zhang J, Zhou H, Jiang Z, Liang J, Pei W, Liu Q, Zhou Z, Wang X   +9 more
doaj  

Cytoreductuctive surgery and HIPEC

, 2017
Systemic treatment alone is no longer appropriate for patients with limited peritoneal dissemination from primary or recurrent colon cancer. A clinical pathway for the management of these patients should include cytoreductive surgery and HIPEC. There are four specific problems that have to be resolved in the future in order to improve survival of the ...
Kekez, Tihomir, Kinda, Emil, Jelinčić, Željko, Majerović, Mate, Golem, Ante Zvonimir, Silovski Hrvoje, Augustin, Goran, Matošević, Petar, Bruketa, Tomislav, Bogdanić, Branko, Majsec Budak, Ana   +10 more
openaire   +3 more sources

Fear of cancer recurrence in peritoneal malignancy patients following complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): an observational study protocol [PDF]

, 2022
Rayan Taher, Sophia Stanford, Norman J. Carr, Nancy Vanderpuye, Kandiah Chandrakumaran   +4 more
openalex   +1 more source